Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRYSTAL: Lesinurad + Febuxostat in Tophaceous Gout
NCT01510769Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Jan 2012; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01510769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510769.